BRCA2 and non-Hodgkin lymphoma: Within the last few years, many studies have focused on the association between BRCA2 gene polymorphisms and cancer risk, including breast cancer, ovarian cancer, non-Hodgkin lymphoma, prostate cancer and others [13–18].